Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,764 public trials 2,078 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

NCT05462717

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +60 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • UC Irvine Cancer Center Orange, California, United States
  • UC Davis Cancer Center Sacramento, California, United States
  • UCSF San Francisco, California, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

NCT04195750

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Faculty Office Towers 1132 ( Site 1538) Birmingham, Alabama, United States
  • University of California San Diego Moores Cancer Center ( Site 1546) La Jolla, California, United States
  • St. Joseph Heritage Healthcare Local Lab ( Site 1531) Santa Rosa, California, United States
  • University of Colorado Cancer Center ( Site 1540) Aurora, Colorado, United States
View all 172 locations
View Trial Details
Active, Not Recruiting

Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial

NCT05411081

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 199 locations
View Trial Details
Active, Not Recruiting

Paediatric Hepatic International Tumour Trial

NCT03017326

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Cliniques Universitaires Saint-Luc Brussels, Woluwe-Saint-Lambert, Belgium
  • University Hospital Motol Prague, Czechia
  • Kuopio University Hospital Kuopio, Finland
View all 32 locations
View Trial Details
Active, Not Recruiting

Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC

NCT04550260

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • Research Site Atlanta, Georgia, United States
  • Research Site Louisville, Kentucky, United States
  • Research Site Dallas, Texas, United States
  • Research Site Fairfax, Virginia, United States
View all 133 locations
View Trial Details
Active, Not Recruiting

THIO Sequenced With Cemiplimab in Advanced NSCLC

NCT05208944

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +14 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • Summit Health Florham Park, New Jersey, United States
  • Sunshine Coast Haematology and Oncology Clinic Buderim, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View all 35 locations
View Trial Details
Active, Not Recruiting

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

NCT02496208

Conditions
Adenocarcinoma, Bladder Small Cell Neuroendocrine Carcinoma, Bladder Squamous Cell Carcinoma, +54 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View Trial Details

Related conditions